SYNTHETIC BIOLOGICS

Synthetic Biologics is a late-stage biotechnology company focused on developing gut microbiome therapeutics. Its portfolio includes SYN-010, which is intended to treat the underlying causes of irritable bowel syndrome with constipation; and SYN-004 (ribaxamase), which aims to defend the gut microbiome from the effects of regularly used intravenous drugs for the prevention of C. difficile infection, antibiotic-associated diarrhea, and the emergence of antibiotic-resistant organisms. The company is also developing monoclonal antibody therapies for the treatment of pertussis and novel discovery-stage biotherapeutics for the treatment of phenylketonuria.

#SimilarOrganizations #People #Financial #Website #More

SYNTHETIC BIOLOGICS

Social Links:

Facebook

Twitter

Industry:

Biotechnology Health Care Therapeutics

Founded:

2001-01-01

Address:

Rockville, Maryland, United States

Country:

United States

Website Url:

http://www.syntheticbiologics.com

Total Employee:

11+

Status:

Active

Contact:

(734) 332-7800

Email Addresses:

[email protected]

Total Funding:

32.88 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Universal Analytics Apache Microsoft Exchange Online

Similar Organizations

aztherapies-logo

AZTherapies

AZTherapies is a clinical stage biotech company developing breakthrough treatments for neuroinflammation-related diseases.

cedilla-therapeutics-logo

Cedilla Therapeutics

Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.

cel-sci-logo

CEL-SCI

CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases.

milestone-pharmaceuticals-logo

Milestone Pharmaceuticals

Milestone Pharmaceuticals is a drug development company developing small molecule therapeutics for the treatment of cardiovascular diseases.

scout-bio-logo

Scout Bio

Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.

Current Employees Featured

john-monahan_image

John Monahan
John Monahan Executive Vice President, Research & Development @ Synthetic Biologics
Executive Vice President, Research & Development

klaus-gottlieb_image

Klaus Gottlieb
Klaus Gottlieb Vice President - Clinical & Regulatory Affairs @ Synthetic Biologics
Vice President - Clinical & Regulatory Affairs
2015-01-01

not_available_image

Jeffrey Riley
Jeffrey Riley Chief Executive Officer, President and Director @ Synthetic Biologics
Chief Executive Officer, President and Director

Founder

khalid-islam_image

Khalid Islam

Stock Details

Company's stock symbol is NYSEMKT:SYN

Acquisitions List

Date	Company	Article	Price
2021-12-14	VCN Biosciences	VCN Biosciences acquired by Synthetic Biologics	N/A

Investors List

msd-partners_image

Official Site Inspections

http://www.syntheticbiologics.com Semrush global rank: 4.93 M Semrush visits lastest month: 1.75 K

Host Informations
Whois Informations

Loading ...